{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:00:46Z","timestamp":1791255646362,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.psyneuen.2007.05.015","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T08:57:35Z","timestamp":1185958655000},"page":"S62-S70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"S1","title":["Genetic heterogeneity of Alzheimer's disease: Complexity and advances"],"prefix":"10.1016","volume":"32","author":[{"given":"Jean-Charles","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Amouyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2007.05.015_bib1","doi-asserted-by":"crossref","unstructured":"American College of Medical Genetics\/American Society of Human Genetics Working Group on ApoE and Alzheimer disease, 1995. Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics\/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. JAMA 274, 1627\u20131629.","DOI":"10.1001\/jama.1995.03530200063039"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0304-3940(94)11107-T","article-title":"Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease","volume":"183","author":"Basun","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1172\/JCI24761","article-title":"The genetic epidemiology of neurodegenerative disease","volume":"115","author":"Bertram","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1086\/505032","article-title":"Single-nucleotide polymorphism rs498055 on chromosome 10q24 is not associated with Alzheimer disease in two independent family samples","volume":"79","author":"Bertram","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ajmg.1320440520","article-title":"Twin studies of Alzheimer disease: II. Some predictions under a genetic model","volume":"44","author":"Breitner","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.arr.2003.07.003","article-title":"The pharmacogenomics of Alzheimer's disease","volume":"3","author":"Crentsil","year":"2004","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/exnr.1994.1191","article-title":"Neurite degeneration elicited by apolipoprotein E peptides","volume":"130","author":"Crutcher","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/302710","article-title":"The number of trait loci in late-onset Alzheimer disease","volume":"66","author":"Daw","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1474-4422(06)70579-8","article-title":"Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study","volume":"5","author":"Elbaz","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and alzheimer disease meta analysis consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/hmg\/ddg037","article-title":"Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community","volume":"12","author":"Farrer","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib14","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1093\/gerona\/52A.2.M117","article-title":"Heritability for Alzheimer's disease: the study of dementia in Swedish twins","volume":"52","author":"Gatz","year":"1997","journal-title":"J. Gerontol. A: Biol. Sci. Med. Sci."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib16","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.285.11.1475","article-title":"Reproductive period and risk of dementia in postmenopausal women","volume":"285","author":"Geerlings","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z","article-title":"Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype","volume":"48","author":"Gibson","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/498851","article-title":"A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease","volume":"78","author":"Grupe","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.20694","article-title":"APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians","volume":"59","author":"Gureje","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(96)01030-2","article-title":"Amyloid, the presenilins and Alzheimer's disease","volume":"20","author":"Hardy","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/JMN:17:2:147","article-title":"Role of apoe\/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy","volume":"17","author":"Holtzman","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib24","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease","volume":"103","author":"Holtzman","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib23","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1529-8817.2004.00110.x","article-title":"Molecular genetics of late-onset Alzheimer's disease","volume":"68","author":"Kamboh","year":"2004","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.61.5.518","article-title":"Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache county study","volume":"61","author":"Khachaturian","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib29","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1212\/01.WNL.0000147294.29309.47","article-title":"Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke","volume":"63","author":"Kolsch","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib30","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1096\/fasebj.12.12.1097","article-title":"Alzheimer's amyloid beta and lipid metabolism: a missing link?","volume":"12","author":"Koudinov","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib31","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/hmg\/ddl142","article-title":"Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease","volume":"15","author":"Kuwano","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1385\/JMN:23:3:225","article-title":"Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene","volume":"23","author":"Lahiri","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib33","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/jnnp.2004.048983","article-title":"Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?","volume":"76","author":"Lambert","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib34","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1172\/JCI8119","article-title":"The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway","volume":"104","author":"Lawn","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer's disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib37","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1073\/pnas.0403535101","article-title":"Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family","volume":"101","author":"Li","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib36","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/hmg\/ddg357","article-title":"Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease","volume":"12","author":"Li","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/01.wnl.0000223438.90113.4e","article-title":"Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease","volume":"67","author":"Lin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archneurpsyc.1934.02250040061004","article-title":"Familial organic psychosis (Alzheimer's type)","volume":"31","author":"Lowenberg","year":"1934","journal-title":"Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib40","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/01.ATV.14.9.1412","article-title":"Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM study","volume":"14","author":"Luc","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/JMN:23:3:235","article-title":"ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function","volume":"23","author":"Manelli","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/496902","article-title":"High-resolution whole-genome association study of Parkinson disease","volume":"77","author":"Maraganore","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/1206","article-title":"APOE genotype predicts when\u2014not whether\u2014one is predisposed to develop Alzheimer disease","volume":"19","author":"Meyer","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2006.08.081","article-title":"Lack of association of two chromosome 10q24 SNPs with Alzheimer's disease","volume":"408","author":"Minster","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib46","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0896-6273(00)80637-6","article-title":"Effects of PS1 deficiency on membrane protein trafficking in neurons","volume":"21","author":"Naruse","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib47","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.8171342","article-title":"Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro","volume":"264","author":"Nathan","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.37.3.359","article-title":"Dementia of the Alzheimer type: clinical and family study of 22 twin pairs","volume":"37","author":"Nee","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2004.06.076","article-title":"Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease","volume":"368","author":"Nishimura","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib50","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neurobiolaging.2004.11.001","article-title":"Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease","volume":"26","author":"Ozturk","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/510686","article-title":"Identification of the genetic basis for complex disorders using pooling-based genome-wide SNP association","volume":"80","author":"Pearson","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1086\/491749","article-title":"Linkage and association studies identify a novel locus for Alzheimer disease at 7q36 in a Dutch population-based sample","volume":"77","author":"Rademakers","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib53","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(96)91272-6","article-title":"Alzheimer's disease in Finnish twins","volume":"347","author":"Raiha","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib54","first-page":"664","article-title":"Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4","volume":"59","author":"Rao","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib55","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.2005.033456","article-title":"Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update","volume":"42","author":"Raux","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib56","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1212\/WNL.44.8.1513","article-title":"Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals","volume":"44","author":"Rebeck","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib57","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(97)80089-X","article-title":"APOE genotyping and response to drug treatment in Alzheimer's disease","volume":"349","author":"Richard","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib58","first-page":"23","article-title":"The familial aggregation of Alzheimer's disease: an epidemiological review","volume":"6","author":"Rocca","year":"1988","journal-title":"Psychiatr. Dev."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib60","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/clpt.1994.205","article-title":"Therapy with l-deprenyl (selegiline) and relation to abuse liability","volume":"56","author":"Schneider","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib61","doi-asserted-by":"crossref","first-page":"11539","DOI":"10.1074\/jbc.M010977200","article-title":"Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation","volume":"276","author":"Schneider","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib62","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib63","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1086\/302280","article-title":"Identifying families with likely genetic protective factors against Alzheimer disease","volume":"64","author":"Silverman","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib64","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.psyneuen.2007.05.015_bib65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/exnr.1994.1019","article-title":"Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype","volume":"125","author":"Strittmatter","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib66","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/504044","article-title":"Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease","volume":"78","author":"Theuns","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib67","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ana.410370510","article-title":"The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival","volume":"37","author":"van Duijn","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib68","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1471-4159.2004.02858.x","article-title":"Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42\/40 ratios","volume":"92","author":"Walker","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2007.05.015_bib69","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","article-title":"Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity","volume":"398","author":"Wolfe","year":"1999","journal-title":"Nature"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453007001333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453007001333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:29:04Z","timestamp":1759681744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453007001333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":69,"alternative-id":["S0306453007001333"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2007.05.015","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic heterogeneity of Alzheimer's disease: Complexity and advances","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2007.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}